Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report

Immune checkpoint inhibitors have markedly changed lung cancer treatment and improved overall survival. However, immune checkpoint inhibitors may be associated with various adverse events, including encephalitis, although this complication is rare. We herein describe the clinical characteristics of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Clin Oncol
Päätekijät: Niki, Maiko, Nakaya, Aya, Kurata, Takayasu, Nakahama, Kahori, Yoshioka, Hiroshige, Kaneda, Toshihiko, Kibata, Kayoko, Ogata, Makoto, Nomura, Shosaku
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2019
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327220/
https://ncbi.nlm.nih.gov/pubmed/30680206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1777
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia